Emerging Trends in Human Tetanus Immunoglobulin Market 2025
Human Tetanus Immunoglobulin (HTIG) is a sterile preparation containing concentrated antibodies derived from the plasma of human donors who have been immunized against tetanus. It is used both for the prevention and treatment of tetanus, a serious and potentially life-threatening condition caused by the toxin produced by the bacterium Clostridium tetani. This bacterium is commonly found in soil, dust, and animal waste. The toxin can enter the body through wounds or injuries, resulting in severe muscle stiffness, spasms, and complications that may affect the respiratory and nervous systems. HTIG provides immediate passive immunity by neutralizing the circulating tetanus toxin before it binds to nerve tissues.